Effects of inhaled nitric oxide on postoperative pulmonary circulation in patients with congenital heart disease

被引:0
|
作者
Matsui, J
Yahagi, N
Kumon, K
Hayashi, H
Watanabe, Y
Haruna, M
Tanigami, H
Yagihara, T
Takamoto, S
Kamiya, T
机构
[1] NATL CARDIOVASC CTR,SURG INTENS CARE UNIT,SUITA,OSAKA 565,JAPAN
[2] NATL CARDIOVASC CTR,DEPT CARDIOVASC SURG,SUITA,OSAKA 565,JAPAN
[3] NATL CARDIOVASC CTR,DEPT PEDIAT,SUITA,OSAKA 565,JAPAN
关键词
nitric oxide; congenital heart disease; cardiac surgery; pulmonary hypertension; pulmonary hypertensive crises;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We studied 22 patients with residual pulmonary hypertension or symptoms of postoperative pulmonary hypertensive crisis. They received low-dose inhalation (10 ppm) of nitric oxide (NO), a selective pulmonary vasodilator, after total correction for congenital heart anomalies. Fifteen minutes of NO inhalation improved the pulmonary circulation and lessened the imbalance in the ventilation-perfusion ratio in both groups. Thus, NO inhalation is effective in the treatment of pulmonary hypertension and in the prevention of pulmonary hypertensive crises after total correction for congenital heart anomalies. All patients continued to receive NO therapeutically. The duration of such therapeutic NO inhalation was well correlated with postoperative Qp/Qs (p = 0.014) and Rp/Rs (p = 0.029).
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [1] Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease
    Morris, K
    Beghetti, M
    Petros, A
    Adatia, I
    Bohn, D
    CRITICAL CARE MEDICINE, 2000, 28 (08) : 2974 - 2978
  • [2] INHALED NITRIC-OXIDE IN CONGENITAL HEART-DISEASE
    ROBERTS, JD
    LANG, P
    BIGATELLO, LM
    VLAHAKES, GJ
    ZAPOL, WM
    CIRCULATION, 1993, 87 (02) : 447 - 453
  • [3] Methemoglobin formation in children with congenital heart disease treated with inhaled nitric oxide after cardiac surgery
    MM Hermon
    G Burda
    J Golej
    H Boigner
    E Stoll
    E Kitzmüller
    G Wollenek
    A Pollak
    G Trittenwein
    Critical Care, 6 (Suppl 1):
  • [4] The Effects of Perioperative Inhaled Iloprost on Pulmonary Hypertension with Congenital Heart Disease
    Sung, Ki Won
    Jeon, Yang Bin
    Kim, Na Yeon
    Park, Kook Yang
    Park, Chul Hyun
    Choi, Chang Hyu
    Choi, Deok Young
    CARDIOLOGY, 2013, 126 (04) : 224 - 229
  • [5] Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary hypertension in children with congenital heart surgery
    Kirbas, Ahmet
    Yalcin, Yalim
    Tanrikulu, Nursen
    Gurer, Onur
    Isik, Omer
    CARDIOLOGY JOURNAL, 2012, 19 (04) : 387 - 394
  • [6] Inhaled low-dose nitric oxide for postoperative care in patients with congenital heart defects
    Shimpo, H
    Mitani, Y
    Tanaka, J
    Mizumoto, T
    Onoda, K
    Tani, K
    Yuasa, H
    Yada, I
    Maruyama, K
    ARTIFICIAL ORGANS, 1997, 21 (01) : 10 - 13
  • [7] Nitric oxide synthases in infants and children with pulmonary hypertension and congenital heart disease
    Thomas Hoehn
    Brigitte Stiller
    Allan R McPhaden
    Roger M Wadsworth
    Respiratory Research, 10
  • [8] Con: Intraoperative use of nitric oxide for treatment of pulmonary hypertension in patients with congenital heart disease is not effective
    Russell, IA
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2001, 15 (02) : 263 - 264
  • [9] Inhaled nitric oxide in patients with pulmonary hypertension due to valvular heart disease and chronic lung disease
    Sakane, M
    Ishimitsu, T
    Ninomiya, H
    Ohtsu, I
    Saito, T
    Yamaguchi, I
    Hasegawa, S
    Sugishita, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1998, 62 (12): : 877 - 882
  • [10] Inhaled Nitric Oxide and Higher Necrotizing Enterocolitis Rates in Congenital Heart Disease Patients
    Menchaca, Alicia D.
    Style, Candace C.
    Kyhl, Tyler A.
    Chawla, Mehak
    Texter, Karen M.
    Olutoye, Oluyinka O.
    JOURNAL OF SURGICAL RESEARCH, 2023, 288 : 166 - 171